SMTL ID : 6vei.1

Crystal Structure of Human Cytosolic Isocitrate Dehydrogenase (IDH1) R132H Mutant in Complex with NADPH and AG-881 (Vorasidenib) Inhibitor

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.10 Å
Oligo State
homo-dimer
Ligands
2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
1 x SO4: SULFATE ION(Non-functional Binders)
1 x 33O: 3,6,9,12,15,18,21,24,27,30,33,36-dodecaoxaoctatriacontane-1,38-diol(Non-covalent)
4 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
1 x ACT: ACETATE ION(Non-functional Binders)
1 x MLA: MALONIC ACID(Non-covalent)
1 x 9UO: 6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine(Non-covalent)
1 x MLT: D-MALATE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Konteatis, Z. et al., Vorasidenib (AG-881): A First-in-Class, Brain-Penetrant Dual Inhibitor of Mutant IDH1 and 2 for Treatment of Glioma. Acs Med.Chem.Lett. (2020)
Release Date
2020-02-05
Peptides
Isocitrate dehydrogenase [NADP] cytoplasmic: AB
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Isocitrate dehydrogenase [NADP] cytoplasmic

Related Entries With Identical Sequence

3inm.1 | 3inm.2 | 4kzo.1 | 4kzo.2 | 4umx.1 | 4umy.1 | 5lge.1 | 5lge.2 | 6adg.1 | 6adg.2 | 6o2z.1 | 6u4j.1 | 6vg0.1 | 6vg0.2